Switglim MP 2mg/500mg/7.5mg Tablet
Marketer
Akumentis Healthcare Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Switglim MP 2mg/500mg/7.5mg Tablet
Diabex Trio 2mg/500mg/7.5mg tablets combine medications to manage blood glucose. This treatment, used alongside diet and exercise, enhances blood sugar regulation in adults with type 2 diabetes. It promotes efficient insulin use, reducing blood sugar. Follow your physician's prescribed dosage and schedule for Diabex Trio. Take it with food to prevent digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then, skip the missed dose. Never double a dose; overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood sugar monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your doctor of kidney, liver, or heart conditions before starting. Pregnant or breastfeeding individuals should also seek medical advice. Kidney function tests will be conducted prior to treatment. Limit alcohol consumption as it may heighten side effect risk.
Uses of Switglim MP 2mg/500mg/7.5mg Tablet
Managing type 2 diabetes
Major Benefits of Switglim MP 2mg/500mg/7.5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Switglim MP 2mg/500mg/7.5mg tablets should be administered with a meal.
Common Side effects of Switglim MP 2mg/500mg/7.5mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Switglim MP 2mg/500mg/7.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. The Switglim MP 2mg/500mg/7.5mg Tablet should be administered with a meal.
How Switglim MP 2mg/500mg/7.5mg Tablet works:
Switglim MP 2mg/500mg/7.5mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts via multiple pathways: reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Switglim MP 2mg/500mg/7.5mg tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Switglim MP 2mg/500mg/7.5mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers before recommending this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Switglim MP 2mg/500mg/7.5mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Caution is advised when administering Switglim MP 2mg/500mg/7.5mg tablets to individuals with impaired kidney function; dosage modification may be necessary. Severe kidney disease contraindicates the use of Switglim MP 2mg/500mg/7.5mg tablets. Physician consultation is recommended. Close monitoring of kidney function is prudent during treatment with this medication.
LiverCAUTION
Patients with liver impairment should exercise caution when using Switglim MP 2mg/500mg/7.5mg tablets, as dose modification may be necessary. Consult your physician for guidance. Switglim MP 2mg/500mg/7.5mg tablets are contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Switglim MP 2mg/500mg/7.5mg Tablet :
Should you forget a Switglim MP 2mg/500mg/7.5mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Switglim MP 2mg/500mg/7.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently